Skip to main content
. 2022 Feb 10;5:123. doi: 10.1038/s42003-022-03059-8

Fig. 4. Vesicle permeabilization and cell toxicity properties of CTD truncated αSN and their oligomers.

Fig. 4

af Vesicle permeabilization by truncated αSN constructs. Permeabilization assays with truncated αSN monomers (a, b), unmodified αSOs (c, d), and ONE-modified αSN monomers (e, f) shows more aggressive behavior for oligomers in comparison to monomers, however, ONE-αSO121 and the shorter ones are not as aggressive as the ONE-αSO125 and longer oligomers. g, h Cell viability with 10 µM oligomer confirms the results of vesicle permeabilization. In h αSOs of αSN121 and longer variants are binned into one group and αSN115 and shorter variants into another. Cell toxicity of each group was compared by ANOVA (in graph pad software). ***p-value ≤ 0.001. Each point is the average of three repeats for permeabilization or four repeats for cell toxicity where error bars show standard deviation. Error bars for h show 95% CI.